Michelle M. Mielke, PHD

The principal research interests of Michelle M. Mielke, Ph.D., are to further the understanding of the epidemiology of neurodegenerative diseases and psychiatric disorders.

A primary focus of Dr. Mielke's research is the identification of biomarkers for the diagnosis, prediction and/or progression of Alzheimer's disease, as well as other neurodegenerative and neuropsychiatric conditions.

Much of her work has emphasized both lipid markers — particularly sphingolipids (ceramides and sphingomyelins) — and neuroimaging markers.